Attached files

file filename
8-K - 8-K - XILINX INCa8-kdocument101613.htm
Exhibit 99.1
Investor Relations Contact:                            
Lori Owen
Xilinx, Inc.
(408) 879-6911
ir@xilinx.com



XILINX ANNOUNCES 2014 FISCAL Q2 SALES INCREASE 3% SEQUENTIALLY;
NEW PRODUCTS DRIVE GROWTH


SAN JOSE, CA, October 16, 2013-- Xilinx, Inc. (Nasdaq: XLNX) today announced second quarter fiscal 2014 sales of $599 million, up 3% from the prior quarter and up 10% from the same quarter of the prior fiscal year. Second quarter fiscal 2014 net income was $141 million or $0.49 per diluted share; including a contingent litigation expense of $29 million, or $0.09 per diluted share.
The Xilinx Board of Directors announced a quarterly cash dividend of $0.25 per outstanding share of common stock, payable on November 27, 2013 to all stockholders of record at the close of business on November 6, 2013.
Additional second quarter comparisons are represented in the charts below:


GAAP Results
(In millions, except EPS)
                                  
 
 
 
 
 
Growth Rates
 
Q2
FY 2014
Q1
FY 2014
Q2
FY 2013
 

Q-T-Q

Y-T-Y
Net revenues
$598.9
$579.0
$543.9
 
3%
10%
Operating income
$163.8
$192.9
$148.1
 
-15%
11%
Net income
$141.5
$157.0
$123.4
 
-10%
15%
Diluted earnings per share
$0.49
$0.56
$0.46
 
-13%
7%


“Sales from Xilinx’s 28-nm products have once again exceeded our expectations, surpassing $80 million in the September quarter. Kintex™-7 sales were particularly strong during the quarter, driven by wired and wireless communication applications,” said Moshe Gavrielov, Xilinx President and Chief Executive Officer. “Additionally, gross margin was 69.5% in the September quarter, up from 65.5% in the same quarter of the prior year. This is the second consecutive quarter that the Company has reported a record gross margin and a strong testament to our on-going margin expansion efforts.”









Net Revenues by Geography:
                        
 
Percentages
 
Growth Rates
 
Q2
FY 2014
Q1
FY 2014
Q2
FY 2013
 

Q-T-Q

Y-T-Y
North America
31%
31%
28%
 
2%
22%
Asia Pacific
38%
36%
36%
 
11%
17%
Europe
22%
24%
26%
 
-6%
-7%
Japan
9%
9%
10%
 
3%
-5%


Net Revenues by End Market:
                     
 
Percentages
 
Growth Rates
 
Q2
FY 2014
Q1
FY 2014
Q2
FY 2013
 

Q-T-Q

Y-T-Y
Communications & Data Center
43%
44%
49%
 
2%
-3%
Industrial, Aerospace & Defense
38%
37%
32%
 
6%
32%
Broadcast, Consumer & Automotive
16%
16%
15%
 
5%
17%
Other
3%
3%
4%
 
-5%
-25%


Net Revenues by Product:
                             
 
Percentages
 
Growth Rates
       
Q2
FY 2014
Q1
FY 2014
Q2
FY 2013
 

Q-T-Q

Y-T-Y
New
36%
30%
20%
 
22%
100%
Mainstream
34%
36%
47%
 
-4%
-22%
Base
27%
30%
29%
 
-5%
4%
Support
3%
4%
4%
 
-4%
0%

Products are classified as follows:

New products: Virtex®‐7, Kintex‐7, Artix™-7, Zynq™-7000, Virtex‐6, Spartan™‐6 products
Mainstream products: Virtex‐5, Spartan‐3 and CoolRunner™‐II products
Base products: Virtex‐4, Virtex‐II, Virtex‐E, Virtex, Spartan-II, Spartan, CoolRunner and XC9500 products
Support products: Configuration solutions, HardWire, Software & Support/Services

Key Statistics:
(Dollars in millions)



 
Q2
FY 2014
Q1
FY 2014
Q2
FY 2013
 
 
 
 
Annual Return on Equity (%)*
19
21
19
Operating Cash Flow
$255
$144
$197
Depreciation Expense
$14
$14
$14
Capital Expenditures
$8
$11
$8
Combined Inventory Days
102
105
109
Revenue Turns (%)
54
56
57

*Return on equity calculation: Annualized net income/average equities, including temporary equity







Highlights – September Quarter Fiscal 2014

The Vivado® Design Suite software, first introduced in April, 2012, continues to receive strong customer adoption.  Over 70% of our 28-nm designs are now using Vivado. Built from the ground up to address productivity bottlenecks in system-level integration and implementation, the Vivado Design Suite continues to lead the PLD industry in overall productivity, ease-of-use and system level integration capabilities; and remains the industry’s only software to support both programmable SOC and 3D designs.

Sales from Industrial and A&D increased 6% sequentially in the September quarter, representing a record 38% of total sales. Xilinx is benefiting from strong customer adoption of the 28-nm platform as well as the industry-wide shift to smarter vision applications such as intelligent imaging, surveillance and machine vision, which are pervasive throughout Industrial, Automotive, AVB and A&D.

Xilinx’s Zynq-7000 All Programmable SoC family continues to gain broad-based customer adoption. Initially targeting longer time-to-revenue markets such as Automotive and Industrial, the Zynq-7000 family is now participating in approximately 40% of wireless designs and is rapidly gaining traction in data center applications. Xilinx remains the only PLD Company generating material sales from a programmable SoC product.

Business Outlook – December Quarter Fiscal 2014
Sales are expected to be up 2% to down 2% sequentially.
Gross margin is expected to be approximately 69%.
Operating expenses are expected to be approximately $225 million, including $2 million of amortization of acquisition-related intangibles.
Other income and expenses are expected to be a net expense of approximately $9 million.
Fully diluted share count is expected to be approximately 291 million.
December quarter tax rate is expected to be approximately 13%.




Conference Call
A conference call will be held today at 2:00 p.m. Pacific Time to discuss the September quarter financial results and management's outlook for the December quarter. The webcast and subsequent replay will be available in the Investor Relations section of the Company's web site at www.investor.xilinx.com. A telephonic replay of the call may be accessed later in the day by calling (855) 859-2056 and referencing confirmation code 76692154. The telephonic replay will be available for two weeks following the live call.









This release contains forward-looking statements and projections. Forward-looking statements and projections can often be identified by the use of forward-looking words such as “expect,” “believe,” “may,” “will,” “could,” “anticipate,” “estimate,” “continue,” “plan,” “intend,” “project” or other similar expressions. Statements that refer to or are based on projections, uncertain events or assumptions also identify forward-looking statements. Such forward looking statements include, but are not limited to, statements related to the semiconductor market, the growth and acceptance of our products, expected revenue growth, the demand and growth in the markets we serve, opportunity for expansion into new markets, and our expectations regarding our business outlook for the December quarter of fiscal 2014. Undue reliance should not be placed on such forward-looking statements and projections, which speak only as of the date they are made. We undertake no obligation to update such forward-looking statements. Actual events and results may differ materially from those in the forward-looking statements and are subject to risks and uncertainties including customer acceptance of our new products, current global economic conditions, the health of our customers and the end markets in which they participate, our ability to forecast end customer demand, a high dependence on turns business, more customer volume discounts than expected, greater product mix changes than anticipated, fluctuations in manufacturing yields, our ability to deliver product in a timely manner, our ability to successfully manage production at multiple foundries, variability in wafer pricing, costs and liabilities associated with current and future litigation, and other risk factors listed in our most recent Form 10-Q and 10-K.


About Xilinx

Xilinx develops All Programmable technologies and devices, beyond hardware to software, digital to analog, and single to multiple die in 3D ICs.  These industry leading devices are coupled with a next-generation design environment and IP to serve a broad range of customer needs, from programmable logic to programmable systems integration.  For more information visit www.xilinx.com.

#1351F
Xilinx, the Xilinx logo, Artix, ISE, Kintex, Spartan, Virtex, Zynq, Vivado, and other designated brands included herein are trademarks of Xilinx in the United States and other countries. All other trademarks are the property of their respective owners.
XLNX-F








XILINX, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(In thousands, except per share amounts)

 
Three Months Ended
 
Six Months Ended
 
September 28, 2013
 
June 29, 2013
 
September 29, 2012
 
September 28, 2013
 
September 29, 2012
Net revenues
$
598,937

 
$
578,955

 
$
543,933

 
$
1,177,892

 
$
1,126,717

Cost of revenues
182,816

 
179,700

 
187,713

 
362,516

 
386,124

Gross margin
416,121

 
399,255

 
356,220

 
815,376

 
740,593

Operating expenses:
 
 
 
 
 
 
 
 
 
Research and development
125,002

 
111,541

 
113,887

 
236,543

 
235,334

Selling, general and administrative
96,339

 
92,387

 
91,928

 
188,726

 
188,129

Amortization of acquisition-related intangibles
2,418

 
2,418

 
2,319

 
4,836

 
4,467

Litigation and contingencies
28,600

 

 

 
28,600

 

Total operating expenses
252,359

 
206,346

 
208,134

 
458,705

 
427,930

 
 
 
 
 
 
 
 
 
 
Operating income
163,762

 
192,909

 
148,086

 
356,671

 
312,663

Interest and other expense, net
10,997

 
9,930

 
10,003

 
20,927

 
19,675

Income before income taxes
152,765

 
182,979

 
138,083

 
335,744

 
292,988

Provision for income taxes
11,304

 
25,956

 
14,646

 
37,260

 
39,720

Net income
$
141,461

 
$
157,023

 
$
123,437

 
$
298,484

 
$
253,268

Net income per common share:
 
 
 
 
 
 
 
 
 
Basic
$
0.53

 
$
0.59

 
$
0.47

 
$
1.12

 
$
0.97

Diluted
$
0.49

 
$
0.56

 
$
0.46

 
$
1.05

 
$
0.93

Cash dividends per common share
$
0.25

 
$
0.25

 
$
0.22

 
$
0.50

 
$
0.44

Shares used in per share calculations:
 
 
 
 
 
 
 
 
 
Basic
268,478

 
264,153

 
260,605

 
265,350

 
262,143

Diluted
290,685

 
280,291

 
270,265

 
284,270

 
272,182










XILINX, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)

 
September 28, 2013
 
March 30, 2013 *
 
(unaudited)
 
 
ASSETS
 
 
 
Current assets:
 
 
 
  Cash, cash equivalents and short-term investments
$
2,264,065

 
$
1,714,745

  Accounts receivable, net
277,539

 
229,175

  Inventories
183,708

 
201,250

  Deferred tax assets and other current assets
75,894

 
152,469

Total current assets
2,801,206

 
2,297,639

Net property, plant and equipment
357,420

 
365,687

Long-term investments
1,436,781

 
1,651,033

Other assets
404,645

 
415,092

Total Assets
$
5,000,052

 
$
4,729,451

 
 
 
 
 
 
 
 
LIABILITIES , TEMPORARY EQUITY AND STOCKHOLDERS' EQUITY
 
 
 
Current liabilities:
 
 
 
  Accounts payable and accrued liabilities
$
357,060

 
$
333,379

  Deferred income on shipments to distributors
68,814

 
53,358

  Deferred tax liabilities
126,211

 
51

  Convertible debentures
930,085

 

Total current liabilities
1,482,170

 
386,788

Convertible debentures

 
922,666

Deferred tax liabilities
269,250

 
415,442

Other long-term liabilities
16,756

 
41,259

Temporary equity
359,549

 

Stockholders' equity
2,872,327

 
2,963,296

Total Liabilities, Temporary Equity and Stockholders' Equity
$
5,000,052

 
$
4,729,451

 
 
 
 
* Derived from audited financial statements
 
 
 








XILINX, INC.
SUPPLEMENTAL FINANCIAL INFORMATION
(Unaudited)
(In thousands)


Three Months Ended
 
Six Months Ended

September 28, 2013
 
June 29, 2013
 
September 29, 2012
 
September 28, 2013
 
September 29, 2012
SELECTED CASH FLOW INFORMATION:
 
 
 
 
 
 
 
 
 
  Depreciation
$
13,976

 
$
14,033

 
$
14,151

 
$
28,009

 
$
28,754

  Amortization
4,885

 
4,885

 
4,188

 
9,770

 
8,455

  Stock-based compensation
23,060

 
20,954

 
19,246

 
44,014

 
36,854

  Net cash provided by operating activities
254,943

 
144,209

 
197,370

 
399,152

 
360,316

  Purchases of property, plant and equipment
8,441

 
11,301

 
7,636

 
19,742

 
15,978

  Payment of dividends to stockholders
67,198

 
66,007

 
57,255

 
133,205

 
115,321

  Repurchases of common stock
69,981

 

 
87,441

 
69,981

 
178,148

  Proceeds from issuance of common stock to employees and excess tax benefit
110,925

 
33,957

 
28,627

 
144,882

 
37,654

 
 
 
 
 
 
 
 
 
 
STOCK-BASED COMPENSATION INCLUDED IN:
 
 
 
 
 
 
 
 
 
  Cost of revenues
$
1,858

 
$
1,804

 
$
1,473

 
$
3,662

 
$
3,201

  Research and development
11,343

 
10,219

 
9,404

 
21,562

 
18,027

  Selling, general and administrative
9,859

 
8,931

 
8,369

 
18,790

 
15,626